Related Articles
Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect
Clinical significance of urinary vascular endothelial growth factor in patients with superficial bladder tumors
Three-day intravesical instillation of anti-cancer drugs for prophylaxis of bladder cancer
Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection.
Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy